Johnson & Johnson's Janssen Biotech Inc. subsidiary will provide guidance on BioPontis' early science and development programs to help ensure that BioPontis' programs align with market demand

BioPontis Alliance for Rare Disease

U.S. / Other

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Johnson & Johnson

U.S. / Large-Cap Biopharma (>=$50 billion)

Advisor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced